Maxcyte (MXCT) Non-Current Assets (2020 - 2026)

Maxcyte (MXCT) has 7 years of Non-Current Assets data on file, last reported at $71.5 million in Q1 2026.

• Quarterly Non-Current Assets fell 3.61% year-over-year to $71.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $321.0 million (up 9.36% YoY) and the FY2025 annual result came in at $84.1 million, up 24.12% from the prior year.
• Non-Current Assets declined to $71.5 million in Q1 2026 per MXCT's latest filing, from $84.1 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $88.8 million in Q3 2025 and bottomed at $25.2 million in Q1 2022.
• The 5-year median for Non-Current Assets is $71.5 million (2026), against an average of $60.0 million.
• The widest annual swing landed in 2022, when Non-Current Assets jumped 318.61%; it then slipped 13.18% in 2024.
• Tracing MXCT's Non-Current Assets over 5 years: stood at $34.4 million in 2022, then soared by 127.06% to $78.1 million in 2023, then declined by 13.18% to $67.8 million in 2024, then advanced by 24.12% to $84.1 million in 2025, then fell by 14.98% to $71.5 million in 2026.
• Per Business Quant, the three latest MXCT Non-Current Assets figures stand at $71.5 million (Q1 2026), $84.1 million (Q4 2025), and $88.8 million (Q3 2025).

Peer Comparison